BranchOut Food Inc. (BOF Quick QuoteBOF - Free Report) shares have surged 89.1% over the past year, sharply outperforming the industry composite’s 22.6% decline and the S&P 500’s 15.2% return. Meanwhile, the stock has significantly outperformed peers MEDIFAST’s (MED Quick QuoteMED - Free Report) 15.8% fall and Lamb Weston’s (LW Quick QuoteLW - Free Report) 32.9% decline.

Image Source: Zacks Investment Research

The rally appears to reflect growing investor confidence that BranchOut is moving beyond a small, launch-driven food business toward a broader manufacturing platform, supported by recurring retail programs, expanding ingredient sales and improving production utilization. While the company still faces execution and margin risks, recent commercial wins provide clearer visibility into how revenues and factory economics could improve over the next several quarters.

Ingredient Expansion Adds Growth Engine

One factor supporting BOF’s strong share-price performance is the rapid development of its ingredient business. After generating approximately $2 million in revenues in 2025, management expects ingredient sales of $6-$7 million in 2026 and believes that the business could exceed $10 million in 2027.

Commercial wins and increased adoption of BranchOut’s fruit and vegetable ingredients by large consumer packaged goods customers are supporting the expansion. Importantly, ingredient sales provide another source of manufacturing volume beyond branded and private-label retail products.

That diversification could become increasingly valuable as BranchOut scales its 50,000-square-foot Peru facility. Higher ingredient volumes can help absorb available manufacturing capacity even when individual branded-product launches fluctuate, potentially improving utilization and spreading fixed production costs over a larger revenue base.

The company’s GentleDry technology and its global exclusive license, subject to two existing licenses, to manufacture dragon-fruit products using EnWave technology further broaden its manufacturing capabilities. Together, these assets give BranchOut multiple channels through which it can drive production growth.

Recurring Retail Wins Improve Revenue Visibility

Another likely reason behind BOF’s rally is the shift from episodic product launches toward larger recurring retail programs.

Second-quarter 2026 net revenues increased 36% year over year to $4.46 million from $3.27 million, primarily reflecting bulk strawberry ingredient sales and the launch of a branded variety at Sam’s Club. However, the more significant development is the expansion of the Sam’s Club relationship into an approximately $8-million annual everyday program covering 309 clubs, with shipments beginning in September 2026.

The same retailer has also placed an additional estimated $2-million Tropical Mix order, with shipments expected to begin in December.

BranchOut is simultaneously launching five branded products with a leading U.S. mass retailer beginning in September. These programs expand the company’s exposure across fruit, vegetable and dairy-based products and reduce its dependence on any single product category.

Based on booked orders, management expects fourth-quarter 2026 revenues of $6-$7 million, whereas it reported $4.5 million in the second quarter. That visibility is important because investors may be assigning greater value to a business with recurring shelf placements and contracted programs than one dependent mainly on irregular launches.

Higher Utilization Could Drive Margin Recovery

The prospect of improving manufacturing economics may also be contributing to the stock’s strength.

BranchOut’s second-quarter gross margin fell sharply to 2.2% from 17.8% a year earlier, partly because the strawberry ingredient program was completed under a compressed procurement schedule that resulted in unusually high raw-material costs.

However, management has since secured future strawberry supply at prices significantly below those incurred during the first half of 2026. Recurring strawberry programs produced during the normal season are expected to generate a gross margin of 40%.

At the same time, booked programs are expected to increase monthly production to 70-80 metric tons during the second half of 2026 from 35-40 metric tons previously. Management estimates that this approximate doubling in factory utilization could reduce fixed manufacturing overhead per pound by roughly half.

This creates an important operating-leverage opportunity. If production rises while procurement costs normalize, incremental revenues could contribute substantially more gross profit than recent results suggest.

Here’s Why BOF Shares Have Rallied So Sharply

Taken together, the stock’s 89.1% advance appears to reflect a change in the market’s expectations for BranchOut rather than simply its current earnings performance.

The company now has several identifiable growth drivers occurring at the same time — a rapidly expanding ingredient business, a sizable recurring Sam’s Club program, additional mass-retail launches and increasing factory utilization. These developments offer greater revenue visibility and a clearer pathway toward improving margins.

Investors may therefore be looking beyond weak near-term profitability and focusing instead on the possibility that BranchOut’s existing manufacturing infrastructure can support substantially higher volumes without a proportionate increase in fixed costs.